Duque MD - Search Results

1

Development of Extended-Release Formulations Containing Cyclobenzaprine Based on Physiologically Based Biopharmaceutics Modeling and Bioequivalence Safe Space.

Miranda Dos Santos E, Ferraz HG, Issa MG, Duque MD. Miranda Dos Santos E, et al. Among authors: duque md. J Pharm Sci. 2023 Dec;112(12):3131-3140. doi: 10.1016/j.xphs.2023.07.012. Epub 2023 Jul 19. J Pharm Sci. 2023. PMID: 37473918

2

Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling.

Issa MG, de Souza NV, Jou BWC, Duque MD, Ferraz HG. Issa MG, et al. Among authors: duque md. Pharmaceutics. 2022 Apr 19;14(5):892. doi: 10.3390/pharmaceutics14050892. Pharmaceutics. 2022. PMID: 35631478 Free PMC article.

3

Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets.

Carapeto GV, Duque MD, Issa MG, Ferraz HG. Carapeto GV, et al. Among authors: duque md. Pharmaceutics. 2023 May 19;15(5):1544. doi: 10.3390/pharmaceutics15051544. Pharmaceutics. 2023. PMID: 37242786 Free PMC article.

4

Application of in Silico Tools in Clinical Practice using Ketoconazole as a Model Drug.

Silva DA, Duque MD, Davies NM, Löbenberg R, Ferraz HG. Silva DA, et al. Among authors: duque md. J Pharm Pharm Sci. 2018;21(1s):242s-253s. doi: 10.18433/jpps30227. J Pharm Pharm Sci. 2018. PMID: 30348250 Free article.

5

In Silico Prediction of Plasma Concentrations of Fluconazole Capsules with Different Dissolution Profiles and Bioequivalence Study Using Population Simulation.

Duque MD, Silva DA, Issa MG, Porta V, Löbenberg R, Ferraz HG. Duque MD, et al. Pharmaceutics. 2019 May 5;11(5):215. doi: 10.3390/pharmaceutics11050215. Pharmaceutics. 2019. PMID: 31060289 Free PMC article.

6

Development of a Discriminative Dissolution Method, Using In-Silico Tool for Hydrochlorothiazide and Valsartan Tablets.

Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Leon RM, et al. Among authors: duque md. Pharmaceutics. 2023 Jun 14;15(6):1735. doi: 10.3390/pharmaceutics15061735. Pharmaceutics. 2023. PMID: 37376183 Free PMC article.

7

Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design.

Duque MD, Kreidel RN, Taqueda ME, Baby AR, Kaneko TM, Velasco MV, Consiglieri VO. Duque MD, et al. Pharm Dev Technol. 2013 Sep-Oct;18(5):1247-54. doi: 10.3109/10837450.2012.693508. Epub 2012 Jun 7. Pharm Dev Technol. 2013. PMID: 22670808

8

Schiff bases of 4-Phenyl-2-Aminothiazoles as hits to new antischistosomals: Synthesis, in vitro, in vivo and in silico studies.

Amorim CR, Pavani TFA, Lopes AFS, Duque MD, Mengarda ACA, Silva MP, de Moraes J, Rando DGG. Amorim CR, et al. Among authors: duque md. Eur J Pharm Sci. 2020 Jul 1;150:105371. doi: 10.1016/j.ejps.2020.105371. Epub 2020 May 7. Eur J Pharm Sci. 2020. PMID: 32389835

9

Efficient drug development of oseltamivir capsules based on process control, bioequivalence and PBPK modeling.

Medeiros JJS, Costa TM, Carmo MP, Nascimento DD, Lauro ENC, Oliveira CA, Duque MD, Prado LD. Medeiros JJS, et al. Among authors: duque md. Drug Dev Ind Pharm. 2022 Apr;48(4):146-157. doi: 10.1080/03639045.2022.2102647. Epub 2022 Jul 24. Drug Dev Ind Pharm. 2022. PMID: 35876070

10

UVA and UVB formulation phototoxicity in a three-dimensional human skin model: Photodegradation effect.

Uco DP, Leite-Silva VR, Silva HDT, Duque MD, Grice J, Mathor MB, Andréo-Filho N, Lopes PS. Uco DP, et al. Among authors: duque md. Toxicol In Vitro. 2018 Dec;53:37-44. doi: 10.1016/j.tiv.2018.07.009. Epub 2018 Jul 26. Toxicol In Vitro. 2018. PMID: 30055310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters